BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9079629)

  • 1. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
    Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A
    J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
    Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
    Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
    Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
    Yamamura Y; Senda H; Noda M; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.
    Miller CP; Heilman DW; Wojchowski DM
    Blood; 2002 Feb; 99(3):898-904. PubMed ID: 11806992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization.
    Gregory RC; Jiang N; Todokoro K; Crouse J; Pacifici RE; Wojchowski DM
    Blood; 1998 Aug; 92(4):1104-18. PubMed ID: 9694697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
    Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL
    J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
    Kapur R; Zhang L
    J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
    Okajima Y; Matsumura I; Nishiura T; Hashimoto K; Yoshida H; Ishikawa J; Wakao H; Yoshimura A; Kanakura Y; Tomiyama Y; Matsuzawa Y
    J Biol Chem; 1998 Sep; 273(36):22877-83. PubMed ID: 9722506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT1 is involved in signal transduction in the EPO induced HEL cells.
    Chu J; Gui CY; Fan J; Tang XD; Qiao RL
    Cell Res; 1998 Jun; 8(2):105-17. PubMed ID: 9669026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
    Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
    J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.